Neola Medical is one of seven companies selected to participate in the new 10XHealth scale-up program developed by SmiLe in close collaboration with Medicon Village and partially funded by the European Regional Development Fund.

The new 10XHealth program is designed for established life science companies in southern Sweden, with the goal of supporting their commercial successes and simultaneously strengthening the life science industry in Skåne. The program runs for a year, during which companies have the opportunity to receive guidance from experts in areas crucial to the scale-up process for a life science company.

“Neola Meical has, since its listing in 2020, rapidly evolved into a commercial company. We set ambitious goals and achieve our milestones. I look forward to, with the support of the 10XHealth program, continuing to accelerate our growth along the positive developmental trajectory we have established.”, says Hanna Sjöström, CEO of Neola Medical.

“This initiative is a crucial part of strengthening the region’s position as one of the most dynamic and expansive in life science in Sweden. It is intended to contribute to our ability to attract and retain successful companies here as role models for the life science sector, including areas such as ATMP.”, says Petter Hartman, CEO of Medicon Village Innovation.

Similar programs are established in countries such as the USA and the UK but are relatively new in a Swedish context. The ambition with 10XHEALTH is to expand the catchment area in the coming years and also invite life science companies from other parts of the country.

The seven companies from Skåne selected to participate in the pilot, starting in January, are Iconovo, Neola Medical, Uman Sense, Paindrainer, NanoEcho, Pila Pharma, and Cyxone.